Fizazi, K <br/><br/>
Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours.  [electronic resource] 

 -  British journal of cancer  May 2002 
 - 1555-60 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>0007-0920 
<br/><br/><label>Standard No.: </label>10.1038/sj.bjc.6600272  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Anemia, Refractory, with Excess of Blasts--chemically induced<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Biomarkers, Tumor--blood<br/>Bleomycin--administration & dosage<br/>Cisplatin--administration & dosage<br/>Cyclophosphamide--administration & dosage<br/>Dactinomycin--administration & dosage<br/>Disease-Free Survival<br/>Doxorubicin--administration & dosage<br/>Etoposide--administration & dosage<br/>Gastrointestinal Diseases--chemically induced<br/>Germinoma--drug therapy<br/>Hematologic Diseases--chemically induced<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Methotrexate--administration & dosage<br/>Middle Aged<br/>Peripheral Nervous System Diseases--chemically induced<br/>Prognosis<br/>Prospective Studies<br/>Remission Induction<br/>Seminoma--drug therapy<br/>Survival Analysis<br/>Survival Rate<br/>Testicular Neoplasms--drug therapy<br/>Treatment Outcome<br/>Vincristine--administration & dosage